轩竹生物(02575)续跌6% 涉与合作企业技术转让纠纷 仲裁赔付933万元

金吾财讯
Jul 21

金吾财讯 | 轩竹生物(02575)低位震荡,报11.14元,跌5.99%,成交额177.6万元。

消息面上,轩竹生物披露仲裁结果,公司与合作生物技术企业因 2021 年药品技术转让合同产生纠纷,对方曾将特定药品国内上市、商业化独家权益转让给轩竹生物,后续该品类仿制药纳入国家集采,同类药品价格大幅下行,叠加研发成果、GMP 核查进度分歧,双方协商合同免责终止无果。

合作方 2024 年向中国国际经济贸易仲裁委员会提交仲裁申请,诉求确认合同终止并索要经济赔偿。仲裁庭于 7 月 15 日出具终局裁决,裁定轩竹生物合计支付约 933 万元人民币,该裁决具备终局法律约束力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10